NCT00521157View on ClinicalTrials.gov

Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions
Opiate Dependence
Interventions
DRUG

Go Medical Naltrexone implants

Naltrexone implants 3.2 g (double of 1,6 g)

Trial Locations (1)

N-0407

Unit for Addiction Medicine, University of Oslo, Oslo

All Listed Sponsors
lead

University of Oslo

OTHER

NCT00521157 - Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction | Biotech Hunter | Biotech Hunter